New Freeze-Heat device offers hope for breast cancer patients avoiding surgery

NCT ID NCT07238894

Recruiting now Disease control Sponsor: Peking University People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 14, 2026 · Updated 3 times

Summary

This study is testing a new device that first freezes and then heats breast tumors to destroy them. It is for patients who cannot have surgery due to health reasons or who choose not to. The goal is to see if this approach can control the cancer and prevent it from coming back, while avoiding the need for breast removal.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Combined Cryoablation and Thermal Ablation system (device that freezes and heats tumors)
What this could lead to: If successful, this could offer a non-surgical option to control breast cancer in patients who cannot undergo surgery, potentially avoiding the need for breast removal.
What could go wrong: This is an early-stage study with only 200 participants, so results may not apply to everyone. The treatment might not fully eliminate the cancer, and there are risks like complications or recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABLATION BREAST CANCER

Contacts and locations

Locations

Peking University People's Hospital
RECRUITING

Beijing, 100000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.